Past events
-
The Economist Ageing Societies 2016
Key figures across international organisations, politics and finance have called for united efforts from government and business to meet the challenges and opportunities presented by an ageing population. Meeting at The Economist Event’s Ageing Societies summit in London on 29th-30th November, key industry and political speakers from organisations including the World Health Organisation, Bupa, OECD, BT, Blackrock, PensionDanmark, HSBC, Danone discussed the impact that the world’s ageing populations will have on current and future generations. -
Stem Cells in Drug Discovery
This meeting was at the Wellcome Genome Campus Conference Centre in Cambridge, UK on 6 - 7 March 2017, attendees will benefit from unrestricted access to all four tracks. Progress in developmental and stem cell biology is revolutionising drug discovery research; the ability to grow and differentiate stem cell lines is providing a far more relevant model for pre-clinical testing. So much so that the FDA is looking into replacing previous models as a matter of urgency. However, challenges in assay development, scale up and quality control still persist and need to be addressed in order for success in this field to continue. -
The Ageing Cell Conference 2017
#THEAGEINGCELL
One of the major achievements of the modern era is the extension of the human lifespan through improvements in medical care, nutrition, sanitation and access to clean water. Over the last century, life expectancy at birth in the UK has risen by almost 30 yrs so that both men and women can now expect to live well into their 80s. This is shifting population demographics; almost 1 in 5 of the UK’s total population is aged 65 or over and this is expected to rise to 1 in 4 by 2050. The Ageing Cell conference will bring together an international community of researchers from academia, industry and the clinic in the fields of immunology, genetics, epigenetics and signalling to discuss ageing at the cellular level. -
BULK ANNUITIES Pension Buy-ins and Buyouts Longevity Insurance and Reinsurance
This conference is the main annual occasion for the leading providers and advisers to come together to exchange views about the latest developments in the bulk annuity and longevity risk transfer market and the factors which will influence its development in the coming year. Although most delegates are from the UK, last year the event also attracted attendees from Canada, USA, Bermuda, Germany, Sweden, Switzerland and Ireland. There is a strong pipeline of business for buy-ins. Pension schemes and solution providers are working well together to produce impressive and affordable outcomes. Longevity risk transfer mechanisms are evolving, notably with increased deal experience in other jurisdictions -
2nd Annual Advances in Immuno-Oncology Congress
Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology Congress, taking place 15-16 May 2017 in London UK. The event features 200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies. 36 presentations and case studies will focus on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies, screening, assays and modelling. On the congress, there were over 300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies. Over 50 presentations and case studies focusing on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies was shown. -
British Society for Research on Aging 67th Annual Scientific Meeting
The aim of this meeting is to show how the -omics technologies allow detailed dissection of ageing processes and age-related disease.
Topics include: Epigenomic trajectories to health and disease, Epigenetic biomarkers of aging and applications, Epigenetic control of gene expression patterns in ageing yeast; Transcriptomics and ageing: from humans to lab models and back again; Understanding age-related changes in redox signalling using proteomics; Building haystacks and finding needles in the genomics of ageing, Senescence: from young to old and back again? How aging impacts the response to influenza; Chromosome behavioural changes in old cells. -
Alzheimer’s Association International Conference
This event showcases like foster an atmosphere to encourage research opportunities of care management for persons engaged with Alzheimer etc. in the Medical & Pharmaceutical industry. For the 2016 year, for example, Canadian researchers presented at AAIC the next observations:
Discoveries identifying biomarkers of memory resilience in people with Alzheimer’s disease and preserved motor function in people with Parkinson’s disease, which may offer new targets for treatment.
Creative and evidence-based methods of delivering culturally appropriate dementia care to several First Nation (Indigenous) communities in the province of Ontario.
An Ontario-based physical and social recreation program provides significant improvements in physical function, activity and agility for people with dementia. -
Master Investor Show
The second big data in biology and health meeting explored the
opportunities and challenges of big data in biology, health and disease
and provide a forum for scientists and clinicians from academia and
industry to drive the future development of research in this area. Individualised medicine based on patient genomes will have an enormous
impact on healthcare. With breakthroughs in DNA sequencing technology,
the number of sequenced genomes could reach >1 million within 5–10
years. The simultaneous generation and integration of this associated
molecular and clinical data will provide an unprecedentedly rich set of
‘big data’ for basic research and translation. Integration of these data
will provide new research opportunities, for example, through the
identification of novel biomarkers or by enabling the identification of
causal relationships in molecular biology through analysing complex
datasets, but will also come with significant technical and bioethical
challenges. -
Big Data in Biology and Health
The second big data in biology and health meeting will explore the opportunities and challenges of big data in biology, health and disease and provide a forum for scientists and clinicians from academia and industry to drive the future development of research in this area. Individualised medicine based on patient genomes will have an enormous impact on healthcare. With breakthroughs in DNA sequencing technology, the number of sequenced genomes could reach >1 million within 5–10 years. The simultaneous generation and integration of this associated molecular and clinical data will provide an unprecedentedly rich set of ‘big data’ for basic research and translation. Integration of these data will provide new research opportunities, for example, through the identification of novel biomarkers or by enabling the identification of causal relationships in molecular biology through analysing complex datasets, but will also come with significant technical and bioethical challenges. -
Oxford Global 3rd Annual Cell/ Gene Therapy Congress
Cell & Gene Therapy: Development & Clinical Trials - Cell Therapy Bioprocessing and Manufacturing Presentations will include cell & gene therapy development, updates in regulatory pathways, commercialisation, bioprocessing and manufacturing. These conferences bring together ver 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. Over 20 presentations and case studies focused on the key issues in cell & gene therapy development, updates in regulatory pathways, commercialisation, bioprocessing and manufacturing are shown here. -
Financial Times Global Pharmaceutical And Biotechnology Conference
The FT Global Pharmaceutical and Biotechnology Conference, in its 35th successful year brought together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry, and the business models and transformation strategies that will be needed to survive and thrive in the new era of unprecedented disruption and uncertainty. -
British Geriatrics Society Autumn Meeting 2017
The BGS Autumn meeting will cover the latest scientific research and the best clinical practice in care of older people. Our ageing population is stimulating extensive NHS service redesign to deal with the challenge of caring for larger numbers of older people both in and out of hospitals. This conference will cover core areas of interest to all specialists responsible for the health care of older people in the United Kingdom. -
The Future of Ageing Conference 2017: Transforming Tomorrow Today
Time for Transformation, a new ‘normal’ – where society has aligned and adapted to the fact we are living longer. The world is going through turbulent times. But one thing is certain – it is getting older. ILC-UK has been active for 16 years and have witnessed some significant change over this time. Yet progress has been far too slow and we are still talking about issues which should have been solved 10 years ago. This conference will aim to reinvigorate those of us already convinced of the importance of ageing. But to achieve the transformation we need must reach beyond the usual suspects. We need businesses, entrepreneurs, people managers, and marketing professionals to work with the charity sector and policy makers and politicians to deliver change. And we need to help provide the evidence to make the case for action. -
The Ageing in Common: an international perspective incorporating the inaugural Commonwealth Elders’ Forum and the NFC UK Conference
The Ageing in Common: an international perspective incorporating the inaugural Commonwealth Elders’ Forum and the NFC UK Conference is being held 16 – 18 April 2018 at at DeVere Wokefield Estate Hotel and Conference Centre, Berkshire, UK. Themes include Human Rights, Women and Dementia, Intergenerational Communities, Leadership, Disruptive Care, the presentation of the first ever Ageing in the Commonwealth research project and much much more. The Elders Forum is linked to the Commonwealth Heads of Government Meeting (CHOGM). At CHOGM leaders from all the Commonwealth member countries will gather in London and Windsor to address the shared global challenges we face and agree how to work to create a better future for all our citizens. The NCF UK Care Conference will look at Human Rights, Nursing, End of Life Care across all UK countries. Hear from CQC and NCF members perspectives as well as diversification and developing Care Models in the UK. -
Aging2.0 OPTIMIZE
Taking place in the iconic Herbst Theater at the War Memorial Building, OPTIMIZE will feature megatrend keynotes, market insights from the c-suite, pitches from carefully curated startups who are in-market with traction, exclusive networking opportunities and an unmatched showcase of cutting-edge exhibitors from around the world. Join senior care providers, health plans, hospital systems, risk takers, thought leaders, investors and top entrepreneurs to discuss the unprecedented confluence of demographic, technological and policy trends that are creating massive needs and opportunities across the continuum of care for older adults. From megatrend keynotes about machine intelligence and the longevity economy to c-suite panels about the shift to value-based care and the future of senior care, the carefully curated combination of thought-provoking content, high-value networking and best-in-class exhibitors makes OPTIMIZE an action and value-packed event that can’t be missed. -
Healthy Ageing Grand Challenge conference
Scheduled for this date in Manchester. Title references the UK government’s 2nd Grand Challenge of the current Industrial Strategy. To be discussed is the current health needs of the UK's older population and how demand is set to increase in the future, how to promote better health in later life and manage long-term conditions such as diabetes, cardiovascular vascular and respiratory diseases, cancer, mental health and dementia, healthy ageing as part of the Industrial Strategy Grand Challenge and how funding is to promote better health and economic benefits. The Healthy Ageing-The Grand Challenge conference agenda will contain expert presentations, discussing the connections between health and later life plus the economic opportunities they present. Delegates will benefit from gaining a greater insight into the required adaptations in approach, products and services to support healthier later life in the communities in which they work. -
Ageing Research and Geriatric Medicine
Ageing and Geriatric Medicine conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Ageing and Geriatric Medicine. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Ageing and Geriatric Medicine. -
Age Tech London 2019
UK medicine professionals in one place
London, the capital of England and the United Kingdom, is a 21st-century city with history stretching back to Roman times. At its centre stand the imposing Houses of Parliament, the iconic ‘Big Ben’ clock tower and Westminster Abbey, site of British monarch coronations. Across the Thames River, the London Eye observation wheel provides panoramic views of the South Bank cultural complex, and the entire city. -
World Agetech and Longevity Congress 2019
Launching in 2019, the World Agetech and Longevity Congress (WALC) is a unique congress and expo for senior-level decision makers from across the burgeoning ecosystem. The content is truly high level, future focussed and transformational, curated by people with deep domain expertise and extensive networks in the life sciences, pharma, agetech, government and investor communities. The global event will focus on industry advancement, providing a platform for attendees to uncover new approaches, share ideas, develop meaningful relationships and do business. There will be a huge array of familiar formats including keynotes, thematic tracks, showcases and a large expo with on-floor seminars, plus novel forums for interaction including CxOforums, qualified 1-2-1 partnering, a hosted buyer program and peer-group receptions and dinners. -
Longevity Leaders Summit Series 2018 / 2019
Launching in 2019, the World Agetech and Longevity Congress (WALC) is a unique congress and expo for senior-level decision makers from across the burgeoning ecosystem. The content is truly high level, future focussed and transformational, curated by people with deep domain expertise and extensive networks in the life sciences, pharma, agetech, government and investor communities. The global event will focus on industry advancement, providing a platform for attendees to uncover new approaches, share ideas, develop meaningful relationships and do business. There will be a huge array of familiar formats including keynotes, thematic tracks, showcases and a large expo with on-floor seminars, plus novel forums for interaction including CxOforums, qualified 1-2-1 partnering, a hosted buyer program and peer-group receptions and dinners.
